Study Stopped
Terminated, because it is not possible to recruit enough participants
Organ Protection by Remote Ischemic Preconditioning for Surgical Treatment of Pediatric Congenital Heart Disease
RIPHeart
1 other identifier
interventional
31
1 country
1
Brief Summary
Cardiac surgery is associated with risk of perioperative inflammation and ischemia leading to cerebral and myocardial morbidity and mortality. Ischemic preconditioning by repetitive ischemic episodes at an organ can reduce damage resulting from consecutive prolonged ischemia in that organ. Remote ischemic preconditioning is defined as ischemic preconditioning by repetitive ischemic episodes of an organ remote from the organ to be protected, e.g. ischemic episodes of a limb can reduce ischemic damage of the heart. Animal studies as well as human studies have shown that ischemic preconditioning can protect the heart from intraoperative ischemia. Remote preconditioning by repetitive limb ischemia has been applied in humans in some studies.12-14 However, the published data is not yet sufficient to support evidence based recommendations for clinical practice. In particular, available data regarding the influence of remote preconditioning on inflammatory and ischemic damage of brain and heart in children following surgery of congenital heart disease are limited. Hence, this prospective, controlled and randomized study was designed to perform remote ischemic preconditioning in children after induction of anesthesia for pediatric heart surgery and to investigate the effect on postoperative organ function in comparison to a control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 8, 2011
CompletedFirst Posted
Study publicly available on registry
March 10, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedNovember 1, 2016
October 1, 2016
4 years
March 8, 2011
October 31, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
serum troponin T
Serum troponin T is measured 8, 16 and 24 hours after end of surgery. Values of serum troponin T are compared between remote ischemic preconditioning group and control group.
48 hours
Study Arms (2)
Remote ischemic preconditioning
EXPERIMENTALRemote ischemic preconditioning at the left leg.
Control
NO INTERVENTIONNo ischemic preconditioning
Interventions
Remote ischemic preconditioning at the left leg.
Eligibility Criteria
You may qualify if:
- congenital heart surgery
You may not qualify if:
- hypoplastic left heart syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Schleswig-Holstein, Campus Kiel
Kiel, Schleswig-Holstein, 24105, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Axel Fudickar, Dr.
University Hospital Schleswig-Holstein
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. med.
Study Record Dates
First Submitted
March 8, 2011
First Posted
March 10, 2011
Study Start
March 1, 2010
Primary Completion
March 1, 2014
Study Completion
May 1, 2014
Last Updated
November 1, 2016
Record last verified: 2016-10
Data Sharing
- IPD Sharing
- Will not share